Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adults-Reference-Cited by-同舟云学术

Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adults

Published:2024-04 Issue: Volume:173 Page:111384
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Sim Yongsik^ORCID,Choi Seo Hee,Lee Narae,Park Yae Won,Ahn Sung Soo,Chang Jong Hee,Kim Se Hoon,Lee Seung-Koo

Funder

National Research Foundation of Korea

Ministry of Education

Publisher

Elsevier BV

Reference42 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019;Ostrom;Neuro Oncol.,2022

2. The 2021 WHO classification of tumors of the central nervous system: a summary;Louis;Neuro Oncol.,2021

3. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol.,2016

4. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions;Wen;Neuro Oncol.,2020

5. Treatment strategies in diffuse midline gliomas with the H3K27M mutation: the role of convection-enhanced delivery in overcoming anatomic challenges;Himes;Front. Oncol.,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of prognostic imaging biomarkers in H3 K27-altered diffuse midline gliomas in adults: impact of tumor oxygenation imaging biomarkers on survival;Neuroradiology;2024-07-16